相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic syndrome and endometrial cancer risk
V. Rosato et al.
ANNALS OF ONCOLOGY (2011)
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
X. -X. He et al.
ANNALS OF ONCOLOGY (2011)
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
Sirwan Hadad et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
Isaam Ben Sahra et al.
CANCER RESEARCH (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Ketones and lactate increase cancer cell stemness, driving recurrence, metastasis and poor clinical outcome in breast cancer
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2011)
A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
Kamlai Saiya-Cork et al.
CLINICAL CANCER RESEARCH (2011)
Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES CARE (2011)
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Matteo Monami et al.
DIABETES CARE (2011)
Comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e53, 2011)
V Basevi et al.
DIABETES CARE (2011)
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
J. A. Johnson et al.
DIABETOLOGIA (2011)
Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
S. C. Larsson et al.
DIABETOLOGIA (2011)
Associations between adipokines and obesity-related cancer
Gilberto Paz-Filho et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
An extended Myc network contributes to glucose homeostasis in cancer and diabetes
Christopher W. Peterson et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells
A. E. Richardson et al.
GROWTH FACTORS (2011)
Metabolic status rather than cell cycle signals control quiescence entry and exit
Damien Laporte et al.
JOURNAL OF CELL BIOLOGY (2011)
Insulin Regulates GLUT1-Mediated Glucose Transport in MG-63 Human Osteosarcoma Cells
Manuel Cifuentes et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Kimberly S. Peairs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells
Han Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Peng Jiang et al.
NATURE CELL BIOLOGY (2011)
Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study
Andreas E. Buchs et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
Dorothee M. Baur et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Qian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Standards of Medical Care in Diabetes-2011 AMERICAN DIABETES ASSOCIATION
DIABETES CARE (2011)
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
Mahvash Zakikhani et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes
Ruslan Novosyadlyy et al.
CANCER RESEARCH (2010)
Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research
Stephen D. Hursting et al.
CARCINOGENESIS (2010)
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
Alejandro Vazquez-Martin et al.
CELL CYCLE (2010)
Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
Insulin Receptor (IR) Pathway Hyperactivity in IGF-IR Null Cells and Suppression of Downstream Growth Signaling Using the Dual IGF-IR/IR Inhibitor, BMS-754807
Joseph E. Dinchuk et al.
ENDOCRINOLOGY (2010)
Insulin-Like Growth Factor-I and Cancer Mortality in Older Men
Jacqueline M. Major et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Paul W. Caton et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome
Michel Pugeat et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
R. J. DeBerardinis et al.
ONCOGENE (2010)
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
Danielle B. Ulanet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism
Shinichi Ota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies
Wensen Chen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
Tomasz P. Srokowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Prostate Cancer
Demetrius Albanes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Insulin Receptor Expression by Human Prostate Cancers
Michael E. Cox et al.
PROSTATE (2009)
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Ricki J. Colman et al.
SCIENCE (2009)
Mitochondria in cancer: Not just innocent bystanders
Christian Frezza et al.
SEMINARS IN CANCER BIOLOGY (2009)
Insulin-like growth factors, their binding proteins, and prostate cancer risk:: Analysis of individual patient data from 12 prospective studies
Andrew W. Roddam et al.
ANNALS OF INTERNAL MEDICINE (2008)
Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels
Tricia Moore et al.
CANCER RESEARCH (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin et al.
CLINICAL BREAST CANCER (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
P53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Keiko Kawauchi et al.
NATURE CELL BIOLOGY (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
FOXOs, cancer and regulation of apoptosis
Z. Fu et al.
ONCOGENE (2008)
Hypoxia and metabolism - Opinion - The interplay between MYC and HIF in cancer
Chi V. Dang et al.
NATURE REVIEWS CANCER (2008)
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
Anna Marie Mulligan et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
Prospective study of hyperglycemia and cancer risk
Par Stattin et al.
DIABETES CARE (2007)
Estrogen receptor alpha (ER alpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alpha T3-1 cell line
Frank Eertmans et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Circulating insulin and C-peptide levels and risk of breast cancer among predominately premenopausal women
A. Heather Eliassen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
Hua Zhang et al.
CANCER RESEARCH (2007)
Diabetes mellitus and risk of bladder cancer: a meta-analysis
S. C. Larsson et al.
DIABETOLOGIA (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation
Nomeli P. Nunez et al.
CANCER RESEARCH (2006)
Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo
TT Tran et al.
ENDOCRINOLOGY (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
AJ Levine et al.
GENES & DEVELOPMENT (2006)
Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway
Piotr Smolewski
ANTI-CANCER DRUGS (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
A prospective study of C-peptide, insulin-like growth factor-1, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women
EK Wei et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
A prospective study of plasma C-peptide and colorectal cancer risk in men
J Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression
F Schwartzenberg-Bar-Yoseph et al.
CANCER RESEARCH (2004)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Diabetes mellitus and risk of prostate cancer: a meta-analysis
S Bonovas et al.
DIABETOLOGIA (2004)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Involvement of the Akt/PKB signaling pathway with disease processes
P Sen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
PAX3/Forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro
M Armoni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells:: reciprocal involvement of PKC-α and PPAR expression
M Okumura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression
XZ Ding et al.
PANCREAS (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
